- Home
- VERV vs CSWI Comparison
VERV vs CSWI Comparison
Compare VERV & CSWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- CSWI
- Stock Information
- Founded
- VERV 2018
- CSWI 2014
- Country
- VERV United States
- CSWI United States
- Employees
- VERV N/A
- CSWI N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- CSWI Home Furnishings
- Sector
- VERV Health Care
- CSWI Industrials
- Exchange
- VERV Nasdaq
- CSWI Nasdaq
- Market Cap
- VERV 384.2M
- CSWI 5.6B
- IPO Year
- VERV 2021
- CSWI N/A
- Fundamental
- Price
- VERV $4.45
- CSWI $305.79
- Analyst Decision
- VERV Strong Buy
- CSWI Buy
- Analyst Count
- VERV 6
- CSWI 4
- Target Price
- VERV $25.75
- CSWI $342.00
- AVG Volume (30 Days)
- VERV 2.9M
- CSWI 98.4K
- Earning Date
- VERV 05-14-2025
- CSWI 05-22-2025
- Dividend Yield
- VERV N/A
- CSWI 0.31%
- EPS Growth
- VERV N/A
- CSWI 28.53
- EPS
- VERV N/A
- CSWI 8.38
- Revenue
- VERV $59,613,000.00
- CSWI $878,301,000.00
- Revenue This Year
- VERV $6.18
- CSWI $13.97
- Revenue Next Year
- VERV N/A
- CSWI $6.79
- P/E Ratio
- VERV N/A
- CSWI $36.49
- Revenue Growth
- VERV 271.44
- CSWI 10.78
- 52 Week Low
- VERV $2.87
- CSWI $248.90
- 52 Week High
- VERV $9.31
- CSWI $436.50
- Technical
- Relative Strength Index (RSI)
- VERV 47.78
- CSWI 45.90
- Support Level
- VERV $3.89
- CSWI $297.25
- Resistance Level
- VERV $4.63
- CSWI $314.56
- Average True Range (ATR)
- VERV 0.41
- CSWI 9.72
- MACD
- VERV 0.02
- CSWI -2.91
- Stochastic Oscillator
- VERV 47.06
- CSWI 20.50
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About CSWI CSW Industrials Inc.
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.